News for hackers. Stuff that matters.
Re:Some Thoughts on Cancer from a Hacker by carbocation on Sunday June 05, 2011 @07:21PM (#2623095)
> because researchers can't yet say why it works it's pretty hard to get trials going in the US

That can't be right. We use plenty of drugs with unknown mechanisms of action. Here's a list:

  4-Aminosalicylic acid 
  Alendronate 
  Ambroxol 
  Arsenic trioxide 
  Becaplermin 
  Bexarotene 
  Chloral hydrate 
  Clofazimine 
  Dactinomycin (RNA synthesis inhibitor) 
  Dapsone (folic acid synthesis inhibitor) 
  Diethyl carbamazine 
  Diethyl ether 
  Diloxanide 
  Dinitric oxide 
  Ethambutol 
  Gentian violet 
  Ginkgolides 
  Griseofulvin 
  Halofantrine 
  Halothane 
  Hydrazinophthalazine 
  Limefantrine (antimalarial; prevents haem polymerization) 
  Levetiracetam 
  Mebendazole 
  Methyl-(5-amino-4-oxopentanoate) 
  Niclosamide 
  Pentamidine 
  Podophyllotoxin 
  Procarbazine 
  Selenium sulphide
Source: http://www.nature.com/nrd/journal/v5/n10/full/nrd2132.html
Re:Some Thoughts on Cancer from a Hacker by reasonattlm on Sunday June 05, 2011 @07:29PM (#2623106)
Per Zheng Cui, the chief obstacle to fundraising for development was that he didn't have a molecular mechanism of operation in hand and explained. I have no reference to hand for that; it might have been in email.

The funded work looking into this, where it exists at all, is presently largely focused on finding that mechanism and thus doing away with the need for donor cells. e.g.

http://www.fightaging.org/archives/2009/12/seeking-funding-t...

Re:Some Thoughts on Cancer from a Hacker by timr on Sunday June 05, 2011 @10:05PM (#2623426)
"Per Zheng Cui, the chief obstacle to fundraising for development was that he didn't have a molecular mechanism of operation in hand and explained."

When you hear people complaining about this, it's a good sign that they're on the extreme margins of whatever field of study they're in, or that they're getting too far ahead of themselves (i.e. trying to pursue clinical studies before basic scientific facts are known). The "mechanism of action" becomes much more important to reviewers when your evidence for efficacy is weak and/or the thing you're advocating tends to go against established scientific theory.

Sometimes the medical establishment is conservative, but this is a feature, not a bug.